These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 18536689)

  • 1. A new path to the cancer epigenome.
    Richon VM
    Nat Biotechnol; 2008 Jun; 26(6):655-6. PubMed ID: 18536689
    [No Abstract]   [Full Text] [Related]  

  • 2. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
    Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
    Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of SATB1 in breast cancer pathogenesis.
    Iorns E; Hnatyszyn HJ; Seo P; Clarke J; Ward T; Lippman M
    J Natl Cancer Inst; 2010 Aug; 102(16):1284-96. PubMed ID: 20595686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer bone metastasis: molecular basis of tissue tropism.
    Kang Y
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):379-80. PubMed ID: 15758269
    [No Abstract]   [Full Text] [Related]  

  • 5. Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.
    España L; Martín B; Aragüés R; Chiva C; Oliva B; Andreu D; Sierra A
    Am J Pathol; 2005 Oct; 167(4):1125-37. PubMed ID: 16192647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is SATB1 a master regulator in breast cancer growth and metastasis?
    Zheng J
    Womens Health (Lond); 2008 Jul; 4(4):329-32. PubMed ID: 19072498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase Cgamma1 is required for metastasis development and progression.
    Sala G; Dituri F; Raimondi C; Previdi S; Maffucci T; Mazzoletti M; Rossi C; Iezzi M; Lattanzio R; Piantelli M; Iacobelli S; Broggini M; Falasca M
    Cancer Res; 2008 Dec; 68(24):10187-96. PubMed ID: 19074886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular signatures associated with transformation and progression to breast cancer in the isogenic MCF10 model.
    Rhee DK; Park SH; Jang YK
    Genomics; 2008 Dec; 92(6):419-28. PubMed ID: 18804527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
    Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
    Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct karyotypes in three breast cancer cell lines --21PTCi, 21NTCi, and 21MT-1 --derived from the same patient and representing different stages of tumor progression.
    Xu J; Souter LH; Chambers AF; Rodenhiser DI; Tuck AB
    Cancer Genet Cytogenet; 2008 Oct; 186(1):33-40. PubMed ID: 18786440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "bone" fide predictor of metastasis? Predicting breast cancer metastasis to bone.
    Kominsky SL; Davidson NE
    J Clin Oncol; 2006 May; 24(15):2227-9. PubMed ID: 16636338
    [No Abstract]   [Full Text] [Related]  

  • 14. MicroRNA-10b and breast cancer metastasis.
    Gee HE; Camps C; Buffa FM; Colella S; Sheldon H; Gleadle JM; Ragoussis J; Harris AL
    Nature; 2008 Oct; 455(7216):E8-9; author reply E9. PubMed ID: 18948893
    [No Abstract]   [Full Text] [Related]  

  • 15. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genes that mediate breast cancer metastasis to lung.
    Minn AJ; Gupta GP; Siegel PM; Bos PD; Shu W; Giri DD; Viale A; Olshen AB; Gerald WL; Massagué J
    Nature; 2005 Jul; 436(7050):518-24. PubMed ID: 16049480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
    Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
    J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
    Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
    Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M; Guo N
    Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.